JUPITER LIFE LINE HOSP L Valuation
JLHL · Healthcare · Current price ₹287.5
Is JUPITER LIFE LINE HOSP L undervalued?
DocStoX estimates the fair value of JUPITER LIFE LINE HOSP L at ₹670 per share, versus the current market price of ₹288. That puts the stock about +133.2% below our fair-value estimate, which we read as "Strong Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹253), Relative P/E (₹1,914), Graham floor (₹396), Analyst target (₹341). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹253 (bear) to ₹670 (base) to ₹1,914 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
JUPITER LIFE LINE HOSP L trades at a P/E of 9.7x and a P/B of 6.2x, with a dividend yield of 0.3%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on JUPITER LIFE LINE HOSP L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.